| 53BP1 | p53-binding protein 1 |
| Akt | Protein kinase B |
| AML | Acute myeloid leukaemia |
| AMPK | AMP-activated protein kinase |
| alt-EJ | Alternative end joining |
| ATM | Ataxia-telangiectasia mutated |
| ATR | Ataxia-telangiectasia and Rad3-related protein |
| AURKA | Aurora kinase A |
| AURKB | Aurora kinase B |
| BARD1 | BRCA1-associated RING domain protein 1 |
| BER | Base excision repair |
| BRCA | Breast cancer susceptibility gene/protein |
| CAK | CDK-activating kinase |
| CDK | Cyclin-dependent kinase |
| CHK1 | Checkpoint kinase 1 |
| CIN | Chromosomal instability |
| DDR | DNA damage response |
| DNA-PK | DNA-dependent protein kinase |
| DSB | DNA double-strand break |
| DYRK1A | Dual-specificity tyrosine-phosphorylation-regulated kinase 1A |
| DYRK1B | Dual-specificity tyrosine-phosphorylation-regulated kinase 1B |
| E3 | E3 ubiquitin ligase |
| eIF2α | Eukaryotic translation initiation factor 2 alpha |
| EIF2AK3 | Eukaryotic translation initiation factor 2 alpha kinase 3; gene name for PERK |
| FANCA | Fanconi anaemia complementation group A |
| FHIT | Fragile histidine triad protein |
| FOXO3a | Forkhead box O3 |
| Fyn | Fyn-related Src family tyrosine kinase |
| G2 | Gap 2 phase of the cell cycle |
| G2/M | Gap 2/mitosis transition |
| GSK3β | Glycogen synthase kinase 3 beta |
| H2AX | H2A histone family member X |
| γH2AX | Phosphorylated H2AX |
| HR | Homologous recombination |
| HRD | Homologous recombination deficiency |
| ISR | Integrated stress response |
| KRAS | Kirsten rat sarcoma virus oncogene homologue |
| Lck | Lymphocyte-specific protein tyrosine kinase |
| MAPK | Mitogen-activated protein kinase |
| MAPKAPK2 | Mitogen-activated protein kinase-activated protein kinase 2 |
| MCL-1 | Myeloid cell leukaemia 1 |
| MK2 | MAP kinase-activated protein kinase 2 |
| MPS1 | Monopolar spindle 1 kinase |
| mTOR | Mechanistic target of rapamycin |
| MRE11 | Double-strand break repair protein meiotic recombination 11 |
| Myc | Myc proto-oncogene/transcription factor |
| NEK2 | NIMA-related kinase 2 |
| NER | Nucleotide excision repair |
| NHEJ | Non-homologous end joining |
| NIMA | Never in mitosis A |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| PALB2 | Partner and localiser of BRCA2 |
| PARP | Poly(ADP-ribose) polymerase |
| PARPi | PARP inhibitor |
| PDHK1 | Pyruvate dehydrogenase kinase 1 |
| PERK | protein kinase R (PKR)-like endoplasmic reticulum kinase |
| PI3K | Phosphoinositide 3-kinase |
| PLK1 | Polo-like kinase 1 |
| Pol II | RNA polymerase II |
| PROTAC | Proteolysis-targeting chimera |
| p38 MAPK | p38 mitogen-activated protein kinase |
| p53 | Protein product of TP53 |
| p-RPA | Phosphorylated replication protein A |
| RAD51 | Radiation sensitive protein 51/RAD51 recombinase |
| RAD51B | RAD51 paralog B |
| RAD51C | RAD51 paralog C |
| RAD51D | RAD51 paralog D |
| R-loops | RNA–DNA hybrid structures with displaced single-stranded DNA |
| ROS | Reactive oxygen species |
| RPA | Replication protein A |
| SAC | Spindle assembly checkpoint |
| SFKs | Src family kinases |
| SGK1 | Serum- and glucocorticoid-regulated kinase 1 |
| Src | SRC proto-oncogene tyrosine-protein kinase |
| SSA | Single-strand annealing |
| SSB | DNA single-strand break |
| STAT | Signal transducer and activator of transcription |
| TBK1 | TANK-binding kinase 1 |
| TFIIH | Transcription factor II H |
| TP53 | Tumour protein p53 gene |
| TTK/MPS1 | TTK protein kinase/monopolar spindle 1 kinase |
| UPR | Unfolded protein response |
| WEE1 | Wee1 G2 checkpoint kinase |
| WIP1 | Wild-type p53-induced phosphatase 1 |
| XRCC2 | X-ray repair cross-complementing protein 2 |
| XRCC3 | X-ray repair cross-complementing protein 3 |